Stay updated on Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial
Sign up to get notified when there's something new on the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page.
Latest updates to the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page
- Check5 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.1%
- Check12 days agoChange DetectedThe website has updated the type of intervention and contact information for Danny Wang, while removing the previous version details.SummaryDifference0.5%
- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoNo Change Detected
- Check41 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check48 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for those who can answer questions about joining the study, along with a reference to the Contacts and Locations section.SummaryDifference3%
- Check63 days agoChange DetectedThe website has added new content, while several links and detailed options related to downloads and study data fields have been removed.SummaryDifference4%
- Check70 days agoChange DetectedNew additions include several key health and government websites, such as HHS, NIH, and NLM, enhancing the site's resource offerings.SummaryDifference0.2%
Stay in the know with updates to Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page.